189 related articles for article (PubMed ID: 1975199)
21. The effects of medetomidine and its reversal with atipamezole on plasma glucose, cortisol and noradrenaline in cattle and sheep.
Ranheim B; Horsberg TE; Søli NE; Ryeng KA; Arnemo JM
J Vet Pharmacol Ther; 2000 Dec; 23(6):379-87. PubMed ID: 11168916
[TBL] [Abstract][Full Text] [Related]
22. Effects of atipamezole, a novel alpha 2-adrenoceptor antagonist, in open-field, plus-maze, two compartment exploratory, and forced swimming tests in the rat.
Kauppila T; Tanila H; Carlson S; Taira T
Eur J Pharmacol; 1991 Nov; 205(2):177-82. PubMed ID: 1687467
[TBL] [Abstract][Full Text] [Related]
23. Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.
Milne B; Sutak M; Cahill CM; Jhamandas K
Br J Pharmacol; 2008 Dec; 155(8):1264-78. PubMed ID: 18806811
[TBL] [Abstract][Full Text] [Related]
24. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
25. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.
Virtanen R; Savola JM; Saano V
Arch Int Pharmacodyn Ther; 1989; 297():190-204. PubMed ID: 2567152
[TBL] [Abstract][Full Text] [Related]
26. Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues.
Larsson PT; Martinsson A; Olsson G; Hjemdahl P
Br J Clin Pharmacol; 1989 Dec; 28(6):663-74. PubMed ID: 2558700
[TBL] [Abstract][Full Text] [Related]
27. Antagonistic effects of atipamezole and yohimbine on medetomidine-induced diuresis in healthy dogs.
Talukder MH; Hikasa Y; Takahashi H; Sato K; Matsuu A
Can J Vet Res; 2009 Oct; 73(4):260-70. PubMed ID: 20046627
[TBL] [Abstract][Full Text] [Related]
28. Influence of atipamezole on effects of midsacral subarachnoidally administered detomidine in mares.
Skarda RT; Muir WW
Am J Vet Res; 1998 Apr; 59(4):468-77. PubMed ID: 9563633
[TBL] [Abstract][Full Text] [Related]
29. Effects of three antagonists on selected pharmacodynamic effects of sublingually administered detomidine in the horse.
Knych HK; Stanley SD
Vet Anaesth Analg; 2014 Jan; 41(1):36-47. PubMed ID: 24134603
[TBL] [Abstract][Full Text] [Related]
30. Quantitative in vitro and ex vivo autoradiography of the alpha 2-adrenoceptor antagonist [3H]atipamezole.
Biegon A; Mathis CA; Budinger TF
Eur J Pharmacol; 1992 Nov; 224(1):27-38. PubMed ID: 1360406
[TBL] [Abstract][Full Text] [Related]
31. An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects.
Kernohan AF; McIntyre M; Hughes DM; Tam SW; Worcel M; Reid JL
Br J Clin Pharmacol; 2005 Jan; 59(1):85-93. PubMed ID: 15606445
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the actions of tyrosine by alpha 2-adrenoceptor blockade.
Al-Damluji S; Ross G; Touzel R; Perrett D; White A; Besser GM
Br J Pharmacol; 1988 Oct; 95(2):405-12. PubMed ID: 2906556
[TBL] [Abstract][Full Text] [Related]
33. Assessment of MK-467, a peripheral alpha 2-adrenergic receptor antagonist, with intravenous clonidine.
Warren JB; Dollery CT; Sciberras D; Goldberg MR
Clin Pharmacol Ther; 1991 Jul; 50(1):71-7. PubMed ID: 1677320
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of clonidine and yohimbine on spontaneous pupillary fluctuations in healthy human volunteers.
Phillips MA; Szabadi E; Bradshaw CM
Psychopharmacology (Berl); 2000 May; 150(1):85-9. PubMed ID: 10867980
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats.
Haapalinna A; MacDonald E; Viitamaa T; Salonen JS; Sirviö J; Virtanen R
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):194-203. PubMed ID: 10208306
[TBL] [Abstract][Full Text] [Related]
36. A pharmacodynamic study of the alpha 2-adrenergic receptor antagonist ethoxyidazoxan in healthy volunteers.
Coupland NJ; Bailey JE; Wilson SJ; Potter WZ; Nutt DJ
Clin Pharmacol Ther; 1994 Oct; 56(4):420-9. PubMed ID: 7955803
[TBL] [Abstract][Full Text] [Related]
37. The alpha2-adrenoceptor antagonist atipamezole reduces the development and expression of d-amphetamine-induced behavioural sensitization.
Juhila J; Haapalinna A; Sirviö J; Sallinen J; Honkanen A; Korpi ER; Scheinin M
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):274-80. PubMed ID: 12644900
[TBL] [Abstract][Full Text] [Related]
38. Effects of a selective alpha 2-adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo.
Laitinen KS; Tuomisto L; MacDonald E
Eur J Pharmacol; 1995 Oct; 285(3):255-60. PubMed ID: 8575511
[TBL] [Abstract][Full Text] [Related]
39. The effects of a peripherally selective alpha 2-adrenoceptor antagonist, MK-467, on the metabolic and cardiovascular response to exercise in healthy man.
Sciberras DG; Reed JW; Elliott C; Blain PG; Goldberg MR
Br J Clin Pharmacol; 1994 Jan; 37(1):39-44. PubMed ID: 7908531
[TBL] [Abstract][Full Text] [Related]
40. Partial antagonization of midazolam-medetomidine-ketamine in cats--atipamezole versus combined atipamezole and flumazenil.
Ebner J; Wehr U; Baumgartner C; Erhardt W; Henke J
J Vet Med A Physiol Pathol Clin Med; 2007 Nov; 54(9):518-21. PubMed ID: 17931228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
